Brought to you by 
Mallinckrodt buys InfaCare for $80mm plus earn-outs
04 Sep 2020
Executive Summary
Mallinckrodt PLC will pay $80mm up front to acquire privately held InfaCare Pharmaceutical Corp., which is developing therapies for the neonatal and pediatric markets. The deal also includes up to $345mm in regulatory- and sales-based earn-outs.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Mallinckrodt buys InfaCare for $80mm plus earn-outs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice